APO Research

APO RESEARCH · REPORT

Human Single-Cell Multi-Omics

Selected research

Market Structure

Global Human Single-Cell Multi-Omics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Human Single-Cell Multi-Omics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Human Single-Cell Multi-Omics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Single-Cell Multi-Omics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Single-Cell Multi-Omics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Single-Cell Multi-Omics market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Single-Cell Multi-Omics Segment by Company

10x Genomics

1CellBio

BGI Genomics

Bio-Rad Laboratories

Celsee

Fluidigm Corporation

Fluxion Biosciences

MissionBio

NanoString Technologies

Takara Bio

Human Single-Cell Multi-Omics Segment by Type

Single-Cell Proteomics

Single-Cell Genomics

Single-Cell Transcriptomics

Human Single-Cell Multi-Omics Segment by Application

Synthetic Biology

Clinical Research

Translational Research

Human Single-Cell Multi-Omics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Single-Cell Multi-Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Single-Cell Multi-Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Single-Cell Multi-Omics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Single-Cell Multi-Omics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Single-Cell Multi-Omics industry.

Chapter 3: Detailed analysis of Human Single-Cell Multi-Omics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Single-Cell Multi-Omicsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Single-Cell Proteomics Table 3. Key Players of Single-Cell Genomics Table 4. Key Players of Single-Cell Transcriptomics Table 4. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Synthetic Biology Table 6. Key Players of Clinical Research Table 7. Key Players of Translational Research Table 8. Global Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Human Single-Cell Multi-Omics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Human Single-Cell Multi-Omics Market Share by Region (2021-2026) Table 11. Global Human Single-Cell Multi-Omics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Human Single-Cell Multi-Omics Market Share by Region (2027-2032) Table 13. Human Single-Cell Multi-Omics Industry Trends Table 14. Human Single-Cell Multi-Omics Industry Drivers Table 15. Human Single-Cell Multi-Omics Industry Opportunities and Challenges Table 16. Human Single-Cell Multi-Omics Industry Restraints Table 17. Global Human Single-Cell Multi-Omics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Human Single-Cell Multi-Omics Revenue Market Share by Company (2021-2026) Table 19. Global Human Single-Cell Multi-Omics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Human Single-Cell Multi-Omics Key Company Head Office and Area Served Table 21. Global Human Single-Cell Multi-Omics Company, Product Type & Application Table 22. Global Human Single-Cell Multi-Omics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Human Single-Cell Multi-Omics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Human Single-Cell Multi-Omics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2021-2026) Table 29. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2027-2032) Table 30. Global Human Single-Cell Multi-Omics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021-2026) Table 34. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2027-2032) Table 35. 10x Genomics Company Information Table 36. 10x Genomics Business Overview Table 37. 10x Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. 10x Genomics Human Single-Cell Multi-Omics Product Portfolio Table 39. 10x Genomics Recent Development Table 40. 1CellBio Company Information Table 41. 1CellBio Business Overview Table 42. 1CellBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. 1CellBio Human Single-Cell Multi-Omics Product Portfolio Table 44. 1CellBio Recent Development Table 45. BGI Genomics Company Information Table 46. BGI Genomics Business Overview Table 47. BGI Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BGI Genomics Human Single-Cell Multi-Omics Product Portfolio Table 49. BGI Genomics Recent Development Table 50. Bio-Rad Laboratories Company Information Table 51. Bio-Rad Laboratories Business Overview Table 52. Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio Table 54. Bio-Rad Laboratories Recent Development Table 55. Celsee Company Information Table 56. Celsee Business Overview Table 57. Celsee Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Celsee Human Single-Cell Multi-Omics Product Portfolio Table 59. Celsee Recent Development Table 60. Fluidigm Corporation Company Information Table 61. Fluidigm Corporation Business Overview Table 62. Fluidigm Corporation Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio Table 64. Fluidigm Corporation Recent Development Table 65. Fluxion Biosciences Company Information Table 66. Fluxion Biosciences Business Overview Table 67. Fluxion Biosciences Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio Table 69. Fluxion Biosciences Recent Development Table 70. MissionBio Company Information Table 71. MissionBio Business Overview Table 72. MissionBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. MissionBio Human Single-Cell Multi-Omics Product Portfolio Table 74. MissionBio Recent Development Table 75. NanoString Technologies Company Information Table 76. NanoString Technologies Business Overview Table 77. NanoString Technologies Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio Table 79. NanoString Technologies Recent Development Table 80. Takara Bio Company Information Table 81. Takara Bio Business Overview Table 82. Takara Bio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Takara Bio Human Single-Cell Multi-Omics Product Portfolio Table 84. Takara Bio Recent Development Table 85. North America Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Human Single-Cell Multi-Omics Market Size by Country (2021-2026) Table 91. North America Human Single-Cell Multi-Omics Market Size by Country (2027-2032) Table 92. Europe Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Human Single-Cell Multi-Omics Market Size by Country (2021-2026) Table 98. Europe Human Single-Cell Multi-Omics Market Size by Country (2027-2032) Table 99. China Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 100. China Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 101. China Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 102. China Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Human Single-Cell Multi-Omics Market Size by Country (2021-2026) Table 109. Asia Human Single-Cell Multi-Omics Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Human Single-Cell Multi-Omics Product Image Figure 2. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human Single-Cell Multi-Omics Market Share by Type: 2025 VS 2032 Figure 4. Single-Cell Proteomics Image Figure 5. Single-Cell Genomics Image Figure 6. Single-Cell Transcriptomics Image Figure 7. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Human Single-Cell Multi-Omics Market Share by Application: 2025 VS 2032 Figure 9. Synthetic Biology Image Figure 10. Clinical Research Image Figure 11. Translational Research Image Figure 12. Global Human Single-Cell Multi-Omics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 14. Global Human Single-Cell Multi-Omics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Human Single-Cell Multi-Omics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Human Single-Cell Multi-Omics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Human Single-Cell Multi-Omics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2021-2032) Figure 21. Global Human Single-Cell Multi-Omics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021-2032) Figure 23. North America Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 24. North America Human Single-Cell Multi-Omics Market Share by Type (2021-2032) Figure 25. North America Human Single-Cell Multi-Omics Market Share by Application (2021-2032) Figure 26. North America Human Single-Cell Multi-Omics Market Share by Country (2021-2032) Figure 27. United States Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 28. Canada Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Human Single-Cell Multi-Omics Market Share by Type (2021-2032) Figure 32. Europe Human Single-Cell Multi-Omics Market Share by Application (2021-2032) Figure 33. Europe Human Single-Cell Multi-Omics Market Share by Country (2021-2032) Figure 34. Germany Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 35. France Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 37. Italy Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 38. Russia Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 40. China Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 41. China Human Single-Cell Multi-Omics Market Share by Type (2021-2032) Figure 42. China Human Single-Cell Multi-Omics Market Share by Application (2021-2032) Figure 43. Asia Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 44. Asia Human Single-Cell Multi-Omics Market Share by Type (2021-2032) Figure 45. Asia Human Single-Cell Multi-Omics Market Share by Application (2021-2032) Figure 46. Asia Human Single-Cell Multi-Omics Market Share by Country (2021-2032) Figure 47. Japan Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 51. India Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 52. Australia Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Country (2021-2032) Figure 57. Brazil Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 62. UAE Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 64. Chile Human Single-Cell Multi-Omics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Cell Proteomics
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
Applications
  • Synthetic Biology
  • Clinical Research
  • Translational Research
Companies covered
  • 10x Genomics
  • 1CellBio
  • BGI Genomics
  • Bio-Rad Laboratories
  • Celsee
  • Fluidigm Corporation
  • Fluxion Biosciences
  • MissionBio
  • NanoString Technologies
  • Takara Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Single-Cell Proteomics
  5. 1.2.3 Single-Cell Genomics
  6. 1.2.4 Single-Cell Transcriptomics
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Human Single-Cell Multi-Omics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Synthetic Biology
  10. 1.3.3 Clinical Research
  11. 1.3.4 Translational Research
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Human Single-Cell Multi-Omics Growth Trends by Region
  14. 1.5.1 Global Human Single-Cell Multi-Omics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Human Single-Cell Multi-Omics Market Size by Region (2021-2026)
  16. 1.5.3 Human Single-Cell Multi-Omics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Human Single-Cell Multi-Omics Market Dynamics
  1. 2.1 Human Single-Cell Multi-Omics Industry Trends
  2. 2.2 Human Single-Cell Multi-Omics Industry Drivers
  3. 2.3 Human Single-Cell Multi-Omics Industry Opportunities and Challenges
  4. 2.4 Human Single-Cell Multi-Omics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human Single-Cell Multi-Omics Revenue by Company (2021-2026)
  2. 3.2 Global Human Single-Cell Multi-Omics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human Single-Cell Multi-Omics Key Company Head office and Area Served
  4. 3.4 Global Human Single-Cell Multi-Omics Company, Product Type & Application
  5. 3.5 Global Human Single-Cell Multi-Omics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human Single-Cell Multi-Omics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human Single-Cell Multi-Omics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human Single-Cell Multi-Omics Tier 1, Tier 2, and Tier 3
4 Human Single-Cell Multi-Omics Market by Type
  1. 4.1 Global Human Single-Cell Multi-Omics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human Single-Cell Multi-Omics Market Size by Type (2021-2032)
  3. 4.3 Global Human Single-Cell Multi-Omics Market Size Share by Type (2021-2032)
5 Human Single-Cell Multi-Omics Market by Application
  1. 5.1 Global Human Single-Cell Multi-Omics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Single-Cell Multi-Omics Market Size by Application (2021-2032)
  3. 5.3 Global Human Single-Cell Multi-Omics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 10x Genomics
  2. 6.1.1 10x Genomics Company Information
  3. 6.1.2 10x Genomics Business Overview
  4. 6.1.3 10x Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 10x Genomics Human Single-Cell Multi-Omics Product Portfolio
  6. 6.1.5 10x Genomics Recent Developments
  7. 6.2 1CellBio
  8. 6.2.1 1CellBio Company Information
  9. 6.2.2 1CellBio Business Overview
  10. 6.2.3 1CellBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 1CellBio Human Single-Cell Multi-Omics Product Portfolio
  12. 6.2.5 1CellBio Recent Developments
  13. 6.3 BGI Genomics
  14. 6.3.1 BGI Genomics Company Information
  15. 6.3.2 BGI Genomics Business Overview
  16. 6.3.3 BGI Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BGI Genomics Human Single-Cell Multi-Omics Product Portfolio
  18. 6.3.5 BGI Genomics Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Celsee
  26. 6.5.1 Celsee Company Information
  27. 6.5.2 Celsee Business Overview
  28. 6.5.3 Celsee Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Celsee Human Single-Cell Multi-Omics Product Portfolio
  30. 6.5.5 Celsee Recent Developments
  31. 6.6 Fluidigm Corporation
  32. 6.6.1 Fluidigm Corporation Company Information
  33. 6.6.2 Fluidigm Corporation Business Overview
  34. 6.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio
  36. 6.6.5 Fluidigm Corporation Recent Developments
  37. 6.7 Fluxion Biosciences
  38. 6.7.1 Fluxion Biosciences Company Information
  39. 6.7.2 Fluxion Biosciences Business Overview
  40. 6.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio
  42. 6.7.5 Fluxion Biosciences Recent Developments
  43. 6.8 MissionBio
  44. 6.8.1 MissionBio Company Information
  45. 6.8.2 MissionBio Business Overview
  46. 6.8.3 MissionBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 MissionBio Human Single-Cell Multi-Omics Product Portfolio
  48. 6.8.5 MissionBio Recent Developments
  49. 6.9 NanoString Technologies
  50. 6.9.1 NanoString Technologies Company Information
  51. 6.9.2 NanoString Technologies Business Overview
  52. 6.9.3 NanoString Technologies Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio
  54. 6.9.5 NanoString Technologies Recent Developments
  55. 6.10 Takara Bio
  56. 6.10.1 Takara Bio Company Information
  57. 6.10.2 Takara Bio Business Overview
  58. 6.10.3 Takara Bio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Takara Bio Human Single-Cell Multi-Omics Product Portfolio
  60. 6.10.5 Takara Bio Recent Developments
7 North America
  1. 7.1 North America Human Single-Cell Multi-Omics Market Size (2021-2032)
  2. 7.2 North America Human Single-Cell Multi-Omics Market Size by Type
  3. 7.2.1 North America Human Single-Cell Multi-Omics Market Size by Type (2021-2026)
  4. 7.2.2 North America Human Single-Cell Multi-Omics Market Size by Type (2027-2032)
  5. 7.2.3 North America Human Single-Cell Multi-Omics Market Share by Type (2021-2032)
  6. 7.3 North America Human Single-Cell Multi-Omics Market Size by Application
  7. 7.3.1 North America Human Single-Cell Multi-Omics Market Size by Application (2021-2026)
  8. 7.3.2 North America Human Single-Cell Multi-Omics Market Size by Application (2027-2032)
  9. 7.3.3 North America Human Single-Cell Multi-Omics Market Share by Application (2021-2032)
  10. 7.4 North America Human Single-Cell Multi-Omics Market Size by Country
  11. 7.4.1 North America Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
  13. 7.4.3 North America Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
  14. 7.4.4 North America Human Single-Cell Multi-Omics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human Single-Cell Multi-Omics Market Size (2021-2032)
  2. 8.2 Europe Human Single-Cell Multi-Omics Market Size by Type
  3. 8.2.1 Europe Human Single-Cell Multi-Omics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human Single-Cell Multi-Omics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human Single-Cell Multi-Omics Market Share by Type (2021-2032)
  6. 8.3 Europe Human Single-Cell Multi-Omics Market Size by Application
  7. 8.3.1 Europe Human Single-Cell Multi-Omics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human Single-Cell Multi-Omics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human Single-Cell Multi-Omics Market Share by Application (2021-2032)
  10. 8.4 Europe Human Single-Cell Multi-Omics Market Size by Country
  11. 8.4.1 Europe Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human Single-Cell Multi-Omics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human Single-Cell Multi-Omics Market Size (2021-2032)
  2. 9.2 China Human Single-Cell Multi-Omics Market Size by Type
  3. 9.2.1 China Human Single-Cell Multi-Omics Market Size by Type (2021-2026)
  4. 9.2.2 China Human Single-Cell Multi-Omics Market Size by Type (2027-2032)
  5. 9.2.3 China Human Single-Cell Multi-Omics Market Share by Type (2021-2032)
  6. 9.3 China Human Single-Cell Multi-Omics Market Size by Application
  7. 9.3.1 China Human Single-Cell Multi-Omics Market Size by Application (2021-2026)
  8. 9.3.2 China Human Single-Cell Multi-Omics Market Size by Application (2027-2032)
  9. 9.3.3 China Human Single-Cell Multi-Omics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human Single-Cell Multi-Omics Market Size (2021-2032)
  2. 10.2 Asia Human Single-Cell Multi-Omics Market Size by Type
  3. 10.2.1 Asia Human Single-Cell Multi-Omics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human Single-Cell Multi-Omics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human Single-Cell Multi-Omics Market Share by Type (2021-2032)
  6. 10.3 Asia Human Single-Cell Multi-Omics Market Size by Application
  7. 10.3.1 Asia Human Single-Cell Multi-Omics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human Single-Cell Multi-Omics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human Single-Cell Multi-Omics Market Share by Application (2021-2032)
  10. 10.4 Asia Human Single-Cell Multi-Omics Market Size by Country
  11. 10.4.1 Asia Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human Single-Cell Multi-Omics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human Single-Cell Multi-Omics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research